Literature DB >> 27871053

Quality by Design in the development of hydrophilic interaction liquid chromatography method with gradient elution for the analysis of olanzapine.

Anja Tumpa1, Ana Stajić1, Biljana Jančić-Stojanović2, Mirjana Medenica3.   

Abstract

This paper deals with the development of hydrophilic interaction liquid chromatography (HILIC) method with gradient elution, in accordance with Analytical Quality by Design (AQbD) methodology, for the first time. The method is developed for olanzapine and its seven related substances. Following step by step AQbD methodology, firstly as critical process parameters (CPPs) temperature, starting content of aqueous phase and duration of linear gradient are recognized, and as critical quality attributes (CQAs) separation criterion S of critical pairs of substances are investigated. Rechtschaffen design is used for the creation of models that describe the dependence between CPPs and CQAs. The design space that is obtained at the end is used for choosing the optimal conditions (set point). The method is fully validated at the end to verify the adequacy of the chosen optimal conditions and applied to real samples.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AQbD; Gradient; HILIC; Impurities; Method development; Olanzapine

Mesh:

Substances:

Year:  2016        PMID: 27871053     DOI: 10.1016/j.jpba.2016.11.010

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

Review 1.  Analytical Method Lifecycle Management in Pharmaceutical Industry: a Review.

Authors:  Lúcia Volta E Sousa; Ricardo Gonçalves; José C Menezes; António Ramos
Journal:  AAPS PharmSciTech       Date:  2021-04-09       Impact factor: 3.246

2.  Developing an Improved UHPLC Method for Efficient Determination of European Pharmacopeia Process-Related Impurities in Ropinirole Hydrochloride Using Analytical Quality by Design Principles.

Authors:  Tim Tome; Aleš Obreza; Zdenko Časar
Journal:  Molecules       Date:  2020-06-10       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.